Small team, niche Everist Health is a very small company (2-10 employees) focused on cardiovascular risk tools and COVID-19 risk assessment, indicating a potential need for scalable, enterprise-grade solutions, partnerships, or vendors that support rapid deployment and compliance for medical tech startups.

Clinical tools The core offerings AngioDefender and the Vascular Age Calculator indicate readiness for B2B sales to clinics, hospitals, or health systems seeking quick cardiovascular risk screening and patient engagement capabilities, suggesting value in integration with EHRs or telehealth platforms.

Regulatory alignment CEMark approval for AngioDefender points to regulatory maturity; sales conversations can target risk and compliance teams, highlighting the product’s validated status and potential for reimbursement or coverage discussions with healthcare payers.

Digital footprint Tech stack includes AWS, Google Cloud, and web technologies, signaling openness to cloud-based deployments and integrations; potential upsell opportunities around data analytics, secure data sharing, and API-enabled integrations.

Funding signal With under $1M revenue and $3.1M in funding, there is appetite for strategic partnerships, co-marketing, or channel partnerships with larger health tech players to accelerate market traction and scale distribution.